Breaking News

Top petrochemical executives warned the industry is undergoing a structural shakeout — not a cyclical dip — as oversupply, trade barriers, and China's rising self-sufficiency rewrite the competitive rulebook.

Rising crude oil prices are pushing costs through the pharmaceutical supply chain, with vitamins and sartan APIs leading price increases as capacity cuts and supply disruptions reshape the market.